Clofarabine is a second-generation purine nucleoside analogue that inhibits ribonucleotide reductase and DNA polymerase, used for relapsed or refractory acute lymphoblastic leukaemia in paediatric patients. Simson Pharma's Clofarabine reference standard and impurities support stability-indicating method development for this paediatric oncology agent.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Clofarabine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.